Mechanism of arsenite-mediated decreases in CYP3A23 in rat hepatocytes

Biochemical and Biophysical Research Communications

Volumn 333, Issue 4, 2005, Pages 1211-1217

  Noreault, Trisha L ^a,b   Jacobs, Judith M ^a,b   Nichols, Ralph C ^a,b   Trask, Heidi W ^a,b   Wrighton, Steven A ^c   Sinclair, Peter R ^a,b   Sinclair, Jacqueline F ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Arsenite; Calpain; Calpeptin; CYP3A23; Hepatocyte

Indexed keywords

ARSENIC TRIOXIDE; CALPAIN; CALPASTATIN; CALPEPTIN; CYTOCHROME P450 3A; CYTOCHROME P450 CYP3A23; DEXAMETHASONE; GLUTATHIONE; HEME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 21344446299     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.05.194     Document Type: Article

References (40)

1. D. Vessey Metabolism of drugs and toxins by human liver D. Zakin T. Boyer Hepatology: A textbook of liver diseases 1990 W.B. Saunders Philadelphia 196 234
2. S. Wrighton, M. VandenBranden, and B. Ring The human drug metabolizing cytochromes P450 J. Pharmacokinet. Biopharm. 24 1996 461 473
3. S. Wrighton, E. Schuetz, K. Thummel, D. Shen, K. Korzekwa, and P. Watkins The human CYP3A subfamily: practical considerations Drug Metab. Rev. 32 2000 339 361
4. A. Albores, M. Cebrian, J. Connelly, P. Bach, and J. Bridges Effects of arsenite on hepatic mixed-function oxidase activity in rats Xenobiotica 22 1992 591 597
5. K. Falkner, G. McCallum, M. Cherian, and J. Bend Effects of acute sodium arsenite administration on the pulmonary chemical metabolizing enzymes, cytochrome P-450 monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase in guinea pig: comparison with effects in liver and kidney Chem. Biol. Interact. 86 1993 51 68
6. J. Jacobs, C. Nichols, A. Andrew, D. Marek, S. Wood, P. Sinclair, S. Wrighton, V. Kostrubsky, and J. Sinclair Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes Toxicol. Appl. Pharmacol. 157 1999 51 59
7. D. Vakharia, N. Liu, R. Pause, M. Fasco, E. Bessette, Q. Zhang, and L. Kaminsky Effect of metals on polycyclic aromatic hydrocarbon induction of CYP1A1 and CYP1A2 in human hepatocyte cultures Toxicol. Appl. Pharmacol. 170 2001 93 103
8. M. Sardana, G. Drummond, S. Sassa, and A. Kappas The potent heme oxygenase inducing action of arsenic and parasiticidal arsenicals Pharmacology 23 1981 247 253
9. D. Spink, B. Katz, M. Hussain, B. Spink, S. Wu, N. Liu, P. Pause, and L. Kaminsky Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite Drug Metab. Dispos. 30 2002 262 269
10. J. Jacobs, D. Marek, H. Walton, P. Sinclair, and J. Sinclair Effect of sodium arsenite on heme metabolism in cultured chick embryo hepatocytes Arch. Biochem. Biophys. 371 1999 8 14
11. V. Zgoda, B. Arison, S. Mkrtchian, M. Ingelman-Sundberg, and A. Correia Hemin-mediated restoration of allylisopropylacetamide-inactivated CYP2B1: a role for glutathione and GRP94 in the heme-protein assembly Arch. Biochem. Biophys. 408 2002 58 68
12. A. Barchowsky, E. Dudek, M. Treadwell, and K. Wetterhahn Arsenic induces oxidant stress and NF-KappaB activation in cultured aortic endothelial cells Free Radic. Biol. Med. 21 1996 783 790
13. D. Carter, H. Aposhian, and A. Gandolfi The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review Toxicol. Appl. Pharmacol. 193 2003 309 334
14. D. Thomas, M. Styblo, and S. Lin The cellular metabolism and systemic toxicity of arsenic Toxicol. Appl. Pharmacol. 176 2001 127 144
15. L. Del Razo, B. Quintanilla-Vega, E. Brambila-Colombres, E. Calderon-Aranda, M. Manno, and A. Albores Stress proteins induced by arsenic Toxicol. Appl. Pharmacol. 177 2001 132 148
16. M. Correia, S. Davoll, S. Wrighton, and P. Thomas Degradation of rat liver cytochromes P450 3A after their inactivation by3,5-dicarbethoxy-2,6- dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system Arch. Biochem. Biophys. 297 1992 228 238
17. B. Roberts Evidence of proteasome-mediated cytochrome P-450 degradation J. Biol. Chem. 272 1997 9771 9778
18. H. Wang, M. Figueiredo-Pereira, and M. Correia Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes Arch. Biochem. Biophys. 365 1999 45 53
19. D. Kirkpatrick, K. Dale, J. Catania, and A. Gandolfi Low-level arsenite causes accumulation of ubiquitinated proteins in rabbit renal cortical slices and HEK293 cells Toxicol. Appl. Pharmacol. 186 2003 101 109
20. F. Chen, Z. Zhang, J. Bower, Y. Lu, S. Leonard, M. Ding, V. Catranova, H. Piwnica-Worms, and X. Shi Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway Proc. Natl. Acad. Sci. USA 99 2002 1990 1995
21. P. Sinclair, W. Bement, S. Haugen, J. Sinclair, and P. Guzelian Induction of cytochrome P-450 and 5-aminolevulinate synthase activities in cultured rat hepatocytes Cancer Res. 50 1990 5219 5224
22. E. Schuetz, D. Li, C. Omiecinski, U. Muller-Eberhard, H. Kleinman, B. Elswick, and P. Guzelian Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix J. Cell Physiol. 134 1998 309 323
23. V. Kostrubsky, L. Lewis, S. Wood, P. Sinclair, S. Wrighton, and J. Sinclair Effect of taxol on cytochrome P450 3A and acetaminophen toxicity in cultured rat hepatocytes: comparison to dexamethasone Toxicol. Appl. Pharmacol. 142 1997 79 86
24. B. Rosser, S. Powers, and G. Gores Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach J. Biol. Chem. 268 1993 23593 23600
25. O. Lowry, N. Rosebrough, A. Farr, and R. Randall Protein measurement with the Folin-Phenol reagents J. Biol. Chem. 193 1951 265 275
26. G. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
27. K. DiPetrillo, S. Wood, V. Kostrubsky, K. Chatfield, J. Bement, S. Wrighton, E. Jeffery, P. Sinclair, and J. Sinclair Effect of caffeine on acetaminophen hepatotoxicity in cultured hepatocytes treated with ethanol and isopentanol Toxicol. Appl. Pharmacol. 185 2002 91 97
28. J. Sinclair, S. Wood, E. Smith, P. Sinclair, and D. Koop Comparison of the form(s) of cytochrome P-450 induced by ethanol and glutethimide in cultured chick hepatocytes Biochem. Pharmacol. 38 1989 657 664
29. D. Newton, R. Lang, and A. Lu Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes Drug Metab. Dispos. 23 1995 154 158
30. T. Mossman Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
31. N. Ibrahim, J. Lutton, and R. Levere The role of haem biosynthetic and degradative enzymes in erythroid colony development: the effect of haemin Br. J. Haematol. 50 1982 17 28
32. F. Gonzalez The molecular biology of cytochrome P450s Pharmacol. Rev. 40 1988 243 288
33. R. Zangar, T. Kocarek, S. Shen, N. Bollinger, M. Dahn, and D. Lee Suppression of cytochrome P450 3A protein levels by protease inhibitors J. Pharmacol. Exp. Ther. 305 2003 872 879
34. S. Ekins, G. Bravi, J. Wikel, and S. Wrighton Three-dimensional- quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates J. Pharmacol. Exp. Ther. 291 1999 424 433
35. S. Ekins, G. Bravi, S. Binkley, J. Gillespie, B. Ring, J. Wikel, and S. Wrighton Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors J. Pharmacol. Exp. Ther. 290 1999 429 438
36. J. Maenpaa, S. Hall, B. Ring, S. Strom, and S. Wrighton Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone Pharmacogenetics 8 1998 137 155
37. H. Hamadeh, K. Trouba, R. Amin, C. Afshari, and D. Germolec Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes Toxicol. Sci. 69 2002 306 316
38. J. Wijeweera, A. Gandolfi, A. Parrish, and R. Lantz Sodium arsenite enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in precision-cut rat lung slices Toxicol. Sci. 61 2001 283 294
39. X. Zheng, G. Watts, S. Vaught, and A. Gandolfi Low-level arsenite induced gene expression in HEK293 cells Toxicology 187 2003 39 48
40. C. Brostrom, and M. Brostrom Regulation of translational initiation during cellular responses to stress Prog. Nucleic Acid Res. Mol. Biol. 58 1998 79 125